TY - THES ID - 134533749 TI - Regulation as a barrier to innovation AU - de Goede, Maud AU - Seldeslachts, Jo AU - Boot, Nuria AU - KU Leuven. Faculteit Economie en Bedrijfswetenschappen. Opleiding Master in de Toegepaste Economische Wetenschappen PY - 2018 PB - Leuven KU Leuven. Faculteit Economie en Bedrijfswetenschappen DB - UniCat UR - https://www.unicat.be/uniCat?func=search&query=sysid:134533749 AB - Nowadays, the health expenditures in European countries are increasing. Regulations in the pharmaceutical industry are implemented by the government to suppress these rising health expenditures. The difficulty for the government is that it has to take into consideration two objectives; the health policy objectives and the industrial policy objectives. On one side, the patients have to be secured of safe and effective medicines. But on the other side, drugs research and development and innovations has to be encouraged. Despite these contrasting objectives, the pharmaceutical industry is one of the most regulated industries in the world. Our approach is based on the Community Innovation Survey, to provide empirical evidence for the pharmaceutical industry in the European Union. This paper reveals that the pharmaceutical enterprises consider regulations as an important barrier to innovation. The considered countries Germany, Greece, Italy, Hungary and Poland exhibit very different degrees in importance. ER -